Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines - Wikidata - awgldk - TriplyDB

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

http://www.wikidata.org/entity/Q33591159

about

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers Novel immunotherapeutic approaches to the treatment of urothelial carcinoma Evolving immunotherapy strategies in urothelial cancer Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis Enhanced antimycobacterial response to recombinant Mycobacterium bovis BCG expressing latency-associated peptide.Synthetic biology approaches in drug discovery and pharmaceutical biotechnology.Recombinant Bacille Calmette-Guérin coexpressing Ag85B-IFN-γ enhances the cell-mediated immunity in C57BL/6 mice.Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model.CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.Mycobacterial antigens exacerbate disease manifestations in Mycobacterium tuberculosis-infected mice.The tuberculosis epidemic. Scientific challenges and opportunities Mycobacterium bovis BCG producing interleukin-18 increases antigen-specific gamma interferon production in mice.Recombinant BCG as a vaccine vehicle to protect against tuberculosis.Pharmacotherapy of bladder cancer--practice and prospects.A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in mice Next generation: tuberculosis vaccines that elicit protective CD8+ T cells Th1 cytokine-secreting recombinant Mycobacterium bovis bacillus Calmette-Guérin and prospective use in immunotherapy of bladder cancer.Lethal tuberculosis in interleukin-6-deficient mutant mice Secretion of functional monocyte chemotactic protein 3 by recombinant Mycobacterium bovis BCG attenuates vaccine virulence and maintains protective efficacy against M. tuberculosis infection OX40 ligand fusion protein delivered simultaneously with the BCG vaccine provides superior protection against murine Mycobacterium tuberculosis infection.Manipulation of BCG vaccine: a double-edged sword.Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes Bladder Cancer Immunotherapy: BCG and Beyond.Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer New age adjuvants and delivery systems for subunit vaccines.Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection Vaccine approaches to prevent tuberculosis.Nonmuscle invasive bladder cancer: a primer on immunotherapy.Is intranasal vaccination a feasible solution for tuberculosis?Recombinant vaccines and the development of new vaccine strategies.A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies.Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer.Increased antimycobacterial immunity in interleukin-10-deficient mice.Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent.The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.

P2860

Q24657992-2DAE528A-7AEF-4228-A83C-68861ACD3438 Q26744347-43EF75D7-9B76-4E39-9115-1AB38404D11A Q26823557-00759F08-BDF7-4A0D-A2A3-8E14749EFD90 Q28243702-A0A606FB-CFAD-430E-886C-10B351AEB7A2 Q33552182-EE94A921-20F4-494D-A330-341A01C6ABC7 Q33557182-6BAE79A4-F96C-4011-8CC0-F0631CAFF218 Q33724142-53ABF16E-D3B6-4949-89C9-9FCEB4C82293 Q33756245-4805CA31-BE47-42E9-86B9-1104B751199C Q33933553-63E44ACB-03C0-4740-AA33-50254D28DA6C Q34004438-A86F6543-1F40-47A2-8B2F-97C74A42CC08 Q34120690-DD02E5AE-631E-4564-AFBB-22BC32AD0426 Q34200523-8C938137-8D9D-415E-8A5B-722699A84390 Q34258548-2F4890E1-6190-47E3-994C-A76A1CDA3649 Q34518560-9E42F7CC-CE61-44E1-AF1D-4F102BC4A3B4 Q34660738-FAC4D55E-AFA0-471A-AA99-F25B18282796 Q34784800-D8D0514F-FCE9-4A40-BF97-EAEFC76C82B2 Q35043659-B40B7F1B-E762-41E0-B1DE-1F7E41D0F557 Q35099708-6B93B752-7662-4B04-B8BF-4B73D273A4D6 Q35215350-5A6432C4-D42A-4BD2-A560-3816D2A65756 Q35559120-649993E5-35E1-4752-8770-0311D705A6C3 Q35689094-AB5EA484-B6BF-478A-8895-8D8317083605 Q35766002-AD2208EC-B502-4B73-B1CF-AEEA4E4CEA5F Q35904315-DBAE13C5-520A-47BB-A35B-B1DC6A6E5841 Q36069312-85C0E46B-1777-4649-8ABA-D6525A077E3D Q36072179-7BFBD36E-ED69-4AC0-A3E5-1CE30A80A3EE Q36127825-EBEDE65D-3A83-4733-BAB5-BDC9F683CCA0 Q36265526-E487B017-2CC4-46D3-85EC-7F19CDAADDEB Q36313882-14F56956-9545-4D99-A5D8-749B7E30EFE3 Q36363532-1449C60B-A178-4D08-93F5-86237DB553FD Q36511211-A9DA84AD-6E5E-4F8D-9C2B-AC011A52D643 Q36570685-315FA042-C1D1-4AF6-AF55-13126113576F Q37094072-9C38EE6E-4A04-4843-BECF-219C5158898E Q37316013-1C37DCF3-9F99-4095-B0C5-BAB77573DB62 Q37370940-EA2263ED-988C-4C51-9253-C0022F3E06AC Q37623702-F4FE7E10-605A-4B4E-8B76-AAFD1F54E260 Q38251141-E084288F-2615-446A-BA18-A4869BD27BCB Q38385719-8E4A9D36-F671-4F15-A908-B2D8A22D70C0 Q39510966-B534C9F6-16C1-4E54-AEAE-AA58C6290AA9 Q39517388-EA0D1B41-0EA2-4DED-AE39-D23746D499ED Q39753551-FB5058C4-2D6A-490F-89D2-E44D4D0217F9

P2860

Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines

http://www.wikidata.org/entity/Q33591159

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Manipulation and potentiation ...... strains that secrete cytokines

@ast

Manipulation and potentiation ...... strains that secrete cytokines

@en

type

label

Manipulation and potentiation ...... strains that secrete cytokines

@ast

Manipulation and potentiation ...... strains that secrete cytokines

@en

prefLabel

Manipulation and potentiation ...... strains that secrete cytokines

@ast

Manipulation and potentiation ...... strains that secrete cytokines

@en

P1433

Q33591159-E0DD814C-17D4-47CD-80BA-6497D7889FDD

P1476

Q33591159-C29B3D22-CCFE-4692-93D8-13716E8B3636

P2093

Q33591159-A1006C23-7DE1-4B82-B235-EF23B422F2CB

Q33591159-B5E5499B-FDE6-44AA-96A2-001ADFF1C9D3

Q33591159-DAED9721-49D2-4A4C-B9B6-AF9835C86704

P2860

Q33591159-061C41F0-02FF-4B8A-8839-ADA4175C8493

Q33591159-08AAE70D-F7F7-42C8-A230-24042471631D

Q33591159-0B9C3526-5D0D-4E87-830E-5B1A28AAAC51

Q33591159-0DB8F713-EE5D-4E83-A9AB-7DB8E8F33743

Q33591159-12D4DC69-4923-46F4-ADD7-CA14BB6DFE70

Q33591159-133C42A7-546E-4003-B648-DA8ADDBC8305

Q33591159-1511E149-1586-4D66-A3EC-626A4FEFEAC3

Q33591159-3109B710-B70D-4B67-8739-770363D51124

Q33591159-34105C2C-E80F-4457-A8E5-C37DFCBF827F

Q33591159-3B1C6A94-D98E-411B-970A-2C471884B658

P304

Q33591159-5808ACA8-0A4B-4781-A8C1-E7003E510607

P31

Q33591159-3C9C93C2-565B-42F8-B099-E993D2602280

P356

Q33591159-1A1667BD-47D4-4709-A0C8-9E4138585C39

P407

Q33591159-83892EC4-FAFA-4EC0-98BB-CB2273C10B05

P433

Q33591159-4789D0CF-5F7E-4D41-8CD0-48F110C6B15F

P478

Q33591159-66AE5EA9-60E3-4CFA-8BAF-60BB19ED23C5

P577

Q33591159-DDA1A69F-9705-4EFF-B2C0-D5DC4A2D6226

P5875

Q33591159-8FA102DB-20BE-4761-B78D-9ECB6FA956A9

P698

Q33591159-A45A7137-2D47-4FC1-BD7B-6ABD1F5145B2

P932

Q33591159-64E5C156-B337-467A-81F9-5929C20F2361

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Manipulation and potentiation ...... strains that secrete cytokines

@en

P2093

A Aldovini

http://www.w3.org/2001/XMLSchema#string

P J Murray

http://www.w3.org/2001/XMLSchema#string

R A Young

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Three-dimensional structure of recombinant human interferon-gamma

Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg

Tuberculosis: commentary on a reemergent killer

New use of BCG for recombinant vaccines

Human interleukin 4. The solution structure of a four-helix bundle protein.

Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy.

Immunotherapy for superficial bladder cancer. A developmental and clinical overview.

P304

934-939

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.2.934

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1996-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14629190

http://www.w3.org/2001/XMLSchema#string

P698

8570663

http://www.w3.org/2001/XMLSchema#string

P932

40162

http://www.w3.org/2001/XMLSchema#string